The Journal of Urology
Volume 180, Issue 4, Supplement , Pages 1611-1614, October 2008

Outcome Analysis of Mini-Ureteroneocystostomy Versus Dextranomer/Hyaluronic Acid Copolymer Injection for Unilateral Vesicoureteral Reflux

  • Richard Ashley
  • ,
  • David Vandersteen

      Affiliations

    • Corresponding Author InformationCorrespondence and requests for reprints: 2525 Chicago Ave., Minneapolis, Minnesota 55404 (telephone: 952-835-9442; FAX: 952-835-9443)

Department of Urology, Mayo Clinic, Rochester and Pediatric Surgical Associates (DV), Minneapolis, Minnesota

published online 19 August 2008.

Purpose

Injecting dextranomer/hyaluronic acid copolymer has gained popularity as first line treatment for vesicoureteral reflux. However, ureteroneocystostomy has typically been more successful than endoscopic treatments. We evaluated the outcome of dextranomer/hyaluronic acid copolymer injection vs that of extravesical ureteroneocystostomy via a 2 cm inguinal incision (mini-ureteroneocystostomy) for unilateral vesicoureteral reflux.

Materials and Methods

The records were analyzed of all patients from 2003 to 2007 with unilateral vesicoureteral reflux who underwent mini-ureteroneocystostomy or dextranomer/hyaluronic acid copolymer injection. Mini-ureteroneocystostomy was performed via a 2 cm inguinal incision. Of the injections 66% were delivered via an intraureteral tunnel technique. Statistical analysis was done to compare differences in clinical features and success rates. All p values were 2-sided with significance at p <0.05.

Results

From 2003 to 2007, 99 children underwent operative repair of unilateral vesicoureteral reflux, including 42 via dextranomer/hyaluronic acid copolymer injection and 57 via mini-ureteroneocystostomy. There were no significant differences between the groups in terms of preoperative clinical or anatomical variables except for higher preoperative reflux grade in the mini-ureteroneocystostomy cohort (p <0.001). Patients undergoing mini-ureteroneocystostomy were more likely to be cured (100% vs 78%, p = 0.001). De novo contralateral vesicoureteral reflux occurred in the 2 cohorts to a similar degree (p = 0.15). The injection cohort was more likely to be discharged home on an outpatient basis (100% vs 82%, p = 0.002). No complications occurred in the dextranomer/hyaluronic acid copolymer cohort, while 2 children required intervention for complications after mini-ureteroneocystostomy.

Conclusions

This study details that the 2 procedures may be successfully performed in the outpatient setting, and yet even for more advanced vesicoureteral reflux mini-ureteroneocystostomy achieves greater overall success. This procedure has become our standard of care for unilateral vesicoureteral reflux.

Key Words: bladder, ureter, cystostomy, vesico-ureteral reflux, dextranomer/hyaluronic acid copolymer

Abbreviations and Acronyms: Dx/HA, dextranomer/hyaluronic acid copolymer, UNC, ureteroneocystostomy, VCUG, voiding cystourethrogram, VUR, vesicoureteral reflux

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Study received institutional review board approval.

PII: S0022-5347(08)01148-8

doi:10.1016/j.juro.2008.04.084

The Journal of Urology
Volume 180, Issue 4, Supplement , Pages 1611-1614, October 2008